167 related articles for article (PubMed ID: 22499451)
1. Recruitment, retention and other methodological issues related to clinical trials for Alzheimer's disease.
Vellas B
J Nutr Health Aging; 2012 Apr; 16(4):330. PubMed ID: 22499451
[No Abstract] [Full Text] [Related]
2. Task force on Alzheimer's disease trial methodology: recruitment and retention, data management and analysis. The use of imaging in recruitment: maintenance and methodological issues in Alzheimer's trials.
Suhy J
J Nutr Health Aging; 2012 Apr; 16(4):349-51. PubMed ID: 22499456
[TBL] [Abstract][Full Text] [Related]
3. AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trials.
Vellas B; Pesce A; Robert PH; Aisen PS; Ancoli-Israel S; Andrieu S; Cedarbaum J; Dubois B; Siemers E; Spire JP; Weiner MW; May TS
Alzheimers Dement; 2011 Jul; 7(4):e109-17. PubMed ID: 21784343
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology.
Vellas B; Hampel H; Rougé-Bugat ME; Grundman M; Andrieu S; Abu-Shakra S; Bateman R; Berman R; Black R; Carrillo M; Donohue M; Mintun M; Morris J; Petersen R; Thomas RG; Suhy J; Schneider L; Seely L; Tariot P; Touchon J; Weiner M; Sampaio C; Aisen P;
J Nutr Health Aging; 2012 Apr; 16(4):339-45. PubMed ID: 22499454
[TBL] [Abstract][Full Text] [Related]
5. Recruitment of subjects into clinical trials for Alzheimer disease.
Knebl JA; Patki D
J Am Osteopath Assoc; 2010 Sep; 110(9 Suppl 8):S43-9. PubMed ID: 20926743
[TBL] [Abstract][Full Text] [Related]
6. Pre-dementia Alzheimer's trials: overview.
Aisen PS
J Nutr Health Aging; 2010 Apr; 14(4):294. PubMed ID: 20305998
[TBL] [Abstract][Full Text] [Related]
7. Obstacles and opportunities in Alzheimer's clinical trial recruitment.
Watson JL; Ryan L; Silverberg N; Cahan V; Bernard MA
Health Aff (Millwood); 2014 Apr; 33(4):574-9. PubMed ID: 24711317
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials for early (pre-dementia) Alzheimer's disease: a case for mild cognitive impairment.
Petersen RC
J Nutr Health Aging; 2010 Apr; 14(4):304-5. PubMed ID: 20306001
[TBL] [Abstract][Full Text] [Related]
9. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.
Ryan JM; Schneider G; Jacobsen JS
Alzheimers Dement; 2009 Mar; 5(2):140-2. PubMed ID: 19328445
[No Abstract] [Full Text] [Related]
10. Recruitment methods for United States Alzheimer disease prevention trials.
Schneider LS
J Nutr Health Aging; 2012 Apr; 16(4):331-5. PubMed ID: 22499452
[TBL] [Abstract][Full Text] [Related]
11. Drug development, clinical trials, cultural heterogeneity in Alzheimer disease: the need for pro-active recruitment.
Schneider LS
Alzheimer Dis Assoc Disord; 2005; 19(4):279-83. PubMed ID: 16327360
[TBL] [Abstract][Full Text] [Related]
12. Cyclo-oxygenase inhibitors and Alzheimer's: are we well ADAPTed?
Pasinetti GM; Pompl PN
Lancet Neurol; 2002 Nov; 1(7):403-4. PubMed ID: 12849357
[No Abstract] [Full Text] [Related]
13. Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.
Kennedy RE; Cutter GR; Schneider LS
Alzheimers Dement; 2014 May; 10(3):349-59. PubMed ID: 23712001
[TBL] [Abstract][Full Text] [Related]
14. The perils of Alzheimer's drug development.
Schneider LS; Lahiri DK
Curr Alzheimer Res; 2009 Feb; 6(1):77-8. PubMed ID: 19199878
[No Abstract] [Full Text] [Related]
15. On weighted composite scores for early Alzheimer's trials.
Jin K; Cameron B; Dunn B
Pharm Stat; 2019 Mar; 18(2):239-247. PubMed ID: 30565432
[TBL] [Abstract][Full Text] [Related]
16. Improving drug trials for mild to moderate Alzheimer's disease.
Hogan DB
Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S97-102. PubMed ID: 17469691
[TBL] [Abstract][Full Text] [Related]
17. Are biomarkers harmful to recruitment and retention in Alzheimer's disease clinical trials? An international perspective.
Hampel H; Prvulovic D
J Nutr Health Aging; 2012 Apr; 16(4):346-8. PubMed ID: 22499455
[TBL] [Abstract][Full Text] [Related]
18. What lessons can be learned from failed Alzheimer's disease trials?
Toyn J
Expert Rev Clin Pharmacol; 2015 May; 8(3):267-9. PubMed ID: 25860157
[TBL] [Abstract][Full Text] [Related]
19. Seeing with new eyes: finding a path to early intervention trials in Alzheimer's disease.
Cedarbaum JM; Crans G; Grundman M
J Nutr Health Aging; 2010 Apr; 14(4):306-9. PubMed ID: 20306002
[TBL] [Abstract][Full Text] [Related]
20. Improving recruitment, retention, and adherence to 6-month cycling in Alzheimer's disease.
Yu F
Geriatr Nurs; 2013; 34(3):181-6. PubMed ID: 23414638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
